Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec 1;2019:5496242.
doi: 10.1155/2019/5496242. eCollection 2019.

Clinical Utility of Emergency Capsule Endoscopy for Diagnosing the Source and Nature of Ongoing Overt Obscure Gastrointestinal Bleeding

Affiliations
Free PMC article

Clinical Utility of Emergency Capsule Endoscopy for Diagnosing the Source and Nature of Ongoing Overt Obscure Gastrointestinal Bleeding

Sumio Iio et al. Gastroenterol Res Pract. .
Free PMC article

Abstract

Background and aims: In patients with ongoing overt obscure gastrointestinal bleeding (OGIB), prompt detection of the bleeding source is crucial to treatment success. However, there is no consensus on the optimal timing of diagnostic capsule endoscopy (CE). We investigated the clinical utility of emergency CE for detecting the source of ongoing overt OGIB.

Methods: We retrospectively evaluated 146 consecutive patients who, between February 2009 and July 2018, underwent emergency CE at Hiroshima University Hospital to detect the source of ongoing overt OGIB. Patients with a bleeding source located outside the small bowel were excluded. The remaining 127 patients were stratified according to the timing of CE relative to the onset of bleeding: patients in group A (n = 15, 12 men; mean age: 75 years; age range: 62-83 years) underwent CE within 48 hours of bleeding onset, whereas patients in group B (n = 112, 73 men; mean age: 65 years; age range: 17-88 years) underwent CE at >48 hours after bleeding onset. All patients underwent double-balloon endoscopy, and the final diagnosis was compared against the CE findings.

Results: The CE lesion detection rate was significantly higher in group A (12/15 patients, 80%) than in group B (53/112 patients, 47%) (p = 0.0174). There was no significant difference between the two groups regarding the patients' background characteristics. Vascular lesions were the most frequent finding in both groups. The diagnostic concordance rate between emergency CE and double-balloon endoscopy was 100% in group A and 92.9% in group B. Rebleeding after endoscopic treatment was confirmed in only one patient in group B.

Conclusions: Emergency CE represents a useful diagnostic modality in patients with ongoing overt OGIB, potentially improving detection rates and reducing rebleeding risk.

Conflict of interest statement

The authors declare that there is no conflict of interest regarding the publication of this paper.

Figures

Figure 1
Figure 1
Flow chart of patient enrolment, allocation, and analysis. Consecutive patients with ongoing overt OGIB were stratified according to the timing of CE relative to the onset of bleeding. All patients underwent double-balloon endoscopy, and the final diagnosis was compared against the CE findings. Abbreviations: CE, capsule endoscopy; OGIB, obscure gastrointestinal bleeding.

Similar articles

See all similar articles

References

    1. Raju G. S., Gerson L., Das A., Lewis B., American Gastroenterological Association American gastroenterological association (AGA) institute technical review on obscure gastrointestinal bleeding. Gastroenterology. 2007;133(5):1697–1717. doi: 10.1053/j.gastro.2007.06.007. - DOI - PubMed
    1. Yamamoto H., Ogata H., Matsumoto T., et al. Clinical practice guideline for enteroscopy. Digestive Endoscopy. 2017;29(5):519–546. doi: 10.1111/den.12883. - DOI - PubMed
    1. Nakamura M., Niwa Y., Ohmiya N., et al. Preliminary comparison of capsule endoscopy and double-balloon enteroscopy in patients with suspected small-bowel bleeding. Endoscopy. 2006;38(1):59–66. doi: 10.1055/s-2005-870446. - DOI - PubMed
    1. Kunihara S., Oka S., Tanaka S., et al. Third-generation capsule endoscopy outperforms second-generation based on the detectability of esophageal varices. Gastroenterology Research and Practice. 2016;2016:6. doi: 10.1155/2016/9671327.9671327 - DOI - PMC - PubMed
    1. Kunihara S., Oka S., Tanaka S., Tsuboi A., Otani I., Chayama K. Management of occult obscure gastrointestinal bleeding patients based on long-term outcomes. Therapeutic Advances in Gastroenterology. 2018;11 doi: 10.1177/1756284818787408. - DOI - PMC - PubMed

LinkOut - more resources

Feedback